These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6604705)

  • 1. Modulation of murine lymphoma growth by MDP, MDP(D-D) and cyclophosphamide. 1. Inhibition of growth in vivo.
    Phillips NC; Paraf A; Bahr GM; Chedid L
    Int J Immunopharmacol; 1983; 5(3):219-27. PubMed ID: 6604705
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro inhibition of murine B-cell tumor growth by MDP, MDP(D-D) and Vaccin is mediated by macrophages.
    Moras ML; Phillips NC; Bahr GM; Chedid L
    Int J Immunopharmacol; 1985; 7(4):515-24. PubMed ID: 3876296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the growth of murine thymoma cell lines having different Lyt-phenotypes by MDP and MDP(D-D): macrophage-mediated inhibition of in vitro cell growth.
    Phillips NC; Bahr GM; Modabber FZ; Chedid L
    Int J Immunopharmacol; 1984; 6(6):577-85. PubMed ID: 6334660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
    Castrillón LE
    Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl- L-lysine on resistance to herpes simplex virus type-1 infection in cyclophosphamide-treated mice.
    Ishihara C; Iida J; Mizukoshi N; Yamamoto N; Yamamoto K; Kato K; Azuma I
    Vaccine; 1989 Aug; 7(4):309-13. PubMed ID: 2554602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
    J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological activities of muramyl peptides.
    Bahr GM; Chedid L
    Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target cells for immunomodulatory action of muramyl dipeptide.
    Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
    Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
    Leclerc C; Bourgeois E; Chedid L
    Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
    Taniyama T; Holden HT
    Cell Immunol; 1979 Dec; 48(2):369-74. PubMed ID: 228871
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of in vitro immune responses of murine Peyer's patch cultures by concanavalin A, muramyl dipeptide and lipopolysaccharide.
    Kiyono H; McGhee JR; Kearney JF; Michalek SM
    Scand J Immunol; 1982 Apr; 15(4):329-39. PubMed ID: 7048508
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
    Ishihara C; Yamamoto K; Hamada N; Azuma I
    Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
    Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
    Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
    [No Abstract]   [Full Text] [Related]  

  • 19. Restoration and stimulation of the in vitro immune response of B cells to sheep erythrocytes by interleukins and muramyl dipeptide (MDP).
    Souvannavong V; Adam A
    Biochem Biophys Res Commun; 1984 Nov; 125(1):431-9. PubMed ID: 6334520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties.
    Sollner M; Kotnik V; Pecar S; Stace A; Simcic S; Povsic L; Herzog-Wraber B; Klampfer L; Ihan A; Grosman P
    Agents Actions; 1993 Mar; 38(3-4):273-80. PubMed ID: 8213354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.